Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin in Previously Hypertensive Septic Shock
NCT06125184Unknown
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Nov 2022
- Primary completion
- Oct 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in septic shock comparing Vasopressin Group with Placebo Group (2 arms). Primary endpoint: Serum creatinine change from baseline to 24 hours. Status: unknown.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06125184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125184.